SIRT1 and non-small cell lung carcinoma: This indicates that SIRT1 plays a vital role in the regulation of the NSCLC microenvironment (97), and targeting SIRT1 might represent a potential therapeutic strategy for the treatment of drug-resistant NSCLC.